These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8650721)

  • 1. In vivo evaluation of antiplatelet agents in gerbil model of carotid artery thrombosis.
    Nishimura H; Naritomi H; Iwamoto Y; Tachibana H; Sugita M
    Stroke; 1996 Jun; 27(6):1099-103; discussion 1104. PubMed ID: 8650721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.
    Rote WE; Nedelman MA; Mu DX; Manley PJ; Weisman H; Cunningham MR; Lucchesi BR
    Stroke; 1994 Jun; 25(6):1223-32; discussion 1233. PubMed ID: 8202985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans.
    Bossavy JP; Thalamas C; Sagnard L; Barret A; Sakariassen K; Boneu B; Cadroy Y
    Blood; 1998 Sep; 92(5):1518-25. PubMed ID: 9716578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antiplatelet agents in ischemic cerebrovascular disease.
    Moussouttas M; Papamitsakis N
    Mt Sinai J Med; 2005 Jan; 72(1):16-22. PubMed ID: 15682258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery.
    Kohda N; Tani T; Nakayama S; Adachi T; Marukawa K; Ito R; Ishida K; Matsumoto Y; Kimura Y
    Thromb Res; 1999 Nov; 96(4):261-8. PubMed ID: 10593428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
    Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH
    Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of platelet inhibitors and thrombus formation.
    Meadows TA; Bhatt DL
    Circ Res; 2007 May; 100(9):1261-75. PubMed ID: 17495233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
    Harbison JW
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S17-20. PubMed ID: 9784798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study).
    Hong TT; Huang J; Driscoll E; Lucchesi BR
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):526-33. PubMed ID: 16160608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
    Bhatt DL; Kapadia SR; Yadav JS; Topol EJ
    Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet drugs in secondary prevention of stroke.
    Diener HC
    Int J Clin Pract; 1998 Mar; 52(2):91-7. PubMed ID: 9624789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation and antiaggregation in neurological patients].
    Arnold M; Nedeltchev K; Mattle HP
    Ther Umsch; 2003 Jan; 60(1):33-5. PubMed ID: 12638476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and dipyridamole for the secondary prevention of stroke.
    Zielinski R; French L
    J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiplatelet therapy in the prevention of stroke.
    Easton JD
    Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.